The novel treatment of the medication represents a significant advance in the handling of diabetes mellitus type 2. Different to existing drugs, tirzepatide impacts dual pathways – GLP-1 and GIP – resulting in https://tirzepatidepeptide295940.bloggin-ads.com/65245451/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment